Lanean...
Human Tumor Antigens and Cancer Immunotherapy
With the recent developments of adoptive T cell therapies and the use of new monoclonal antibodies against the immune checkpoints, immunotherapy is at a turning point. Key players for the success of these therapies are the cytolytic T lymphocytes, which are a subset of T cells able to recognize and...
Gorde:
| Argitaratua izan da: | Biomed Res Int |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Hindawi Publishing Corporation
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4487697/ https://ncbi.nlm.nih.gov/pubmed/26161423 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/948501 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|